Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critically Ill Patients
Mycoses · 2025-02 · 68 (2)
DOI: 10.1111/myc.70029 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Mycoses, online erschienen am 03.02.2025. Verfasst von Maria Schroeder und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Antigens, Fungal, Aspergillus, Bronchoalveolar Lavage, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obtaining non‐directed samples from the upper bronchial tree is easier to perform and poses fewer risks for critically ill patients than deep bronchoalveolar lavage (BAL). Since invasive pulmonary aspergillosis is associated with a high mortality in critically ill patients, timely diagnosis and rapid initiation of treatment are of utmost importance.
Objectives
The objective of this study was to compare Galactomannan (GM) testing by Enzyme Immunoassay (EIA), GM Lateral Flow Assay (LFA) and the detection of Aspergillus DNA by Polymerase Chain Reaction (PCR) between directed BAL and non‐directed bronchial lavage (BL) in critically ill patients.
Methods
In this prospective, exploratory pilot study, we analysed 120 samples from 40 patients admitted to 12 mixed intensive care units. Inclusion criteria required either risk factors for IPA or positive Aspergillus assessments and met the criteria published by the European Society of Clinical Microbiology and Infectious Diseases guidelines for IPA diagnosis. Both respiratory secretions and blood were collected. In each patient, LFA and PCR were performed on BAL, BL and blood serum, respectively. The EIA test was applied to the BL and BAL of each patient, and the serum of 24 patients. The study was registered on clinicaltrials.gov (NCT04848831).
Results
In a total of 80 respiratory samples, Aspergillus GM EIA yielded optical density indices (ODI) ranging from 0.04 to ≥ 3.5. We observed a high correlation between BAL and BL samples for Aspergillus GM EIA (Pearson's r = 0.78 [95% CI 0.62, 0.88]; intraclass correlation coefficient 0.78). At an ODI cutoff of 0.8 for BAL and 1.2 for BL, the sensitivity of Aspergillus GM EIA was 0.94, while the specificity was 0.67. Increasing the BAL cutoff to 1.0 ODI improved the specificity to 0.86. Aspergillus PCR examination showed good agreement between the two compartments, with a Cohen's kappa coefficient of 0.75 (95% CI 0.48, 1.00). The correlation of Aspergillus GM LFA between BAL and BL was weak.
Conclusions
Our findings demonstrate that the detection of Aspergillus GM using EIA or Aspergillus PCR in BL is comparable to that in BAL. Thus, BL samples can be reliably used for diagnosing invasive pulmonary aspergillosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Center for Experimental Medicine, Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Center for Diagnostics, Institute of Pathology With the Sections Molecular Pathology and Cytopathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
- Department of Respiratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Maria Schroeder, Tim Hardel
Zitieren
APA
Schroeder, M., Raboh, M. A., Nuechtern, A., Wichmann, D., Stamm, J., Hardel, T., Rohde, H., Christner, M., Ozga, A. K., Steurer, S., Jafari, C., Klose, H., Kluge, S., Simon, M., & Fischer, M. (2025). Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critically Ill Patients. Mycoses, 68(2). https://doi.org/10.1111/myc.70029
Vancouver
Schroeder M, Raboh MA, Nuechtern A, Wichmann D, Stamm J, Hardel T, et al. Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critically Ill Patients. Mycoses. 2025;68(2). doi:10.1111/myc.70029
BibTeX
@article{Schroeder2025,
author = {Schroeder, Maria and Raboh, Mohamad Abd and Nuechtern, Annika and Wichmann, Dominic and Stamm, Johannes and Hardel, Tim and Rohde, Holger and Christner, Martin and Ozga, Ann-Kathrin and Steurer, Stefan and Jafari, Claudia and Klose, Hans and Kluge, Stefan and Simon, Marcel and Fischer, Marlene},
title = {Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non‐Directed Bronchial Lavage and Bronchoalveolar Lavage—A Prospective Exploratory Pilot Study in Critically Ill Patients},
journal = {Mycoses},
year = {2025},
volume = {68},
number = {2},
doi = {10.1111/myc.70029}
}
EUVIMED